Home basEd faecaL calProtectin Measurements Predicting Adalimumab Induction Destiny

NCT02634060 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Crohn Disease
Colitis, Ulcerative

Interventions

DEVICE: Home Based Fecal Calprotectin

Sponsor

Universitaire Ziekenhuizen KU Leuven

Collaborators

[object Object]